SRTS vs. ORCL

Last updated Apr 1, 2026

Compare and contrast key facts about Sensus Healthcare, Inc. (SRTS) and Oracle Corporation (ORCL).

Performance

SRTS vs. ORCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sensus Healthcare, Inc. (SRTS) and Oracle Corporation (ORCL). The values are adjusted to include any dividend payments, if applicable.

SRTS vs. ORCL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SRTS Sensus Healthcare, Inc.	-0.00%	-42.49%	193.22%	-68.19%	2.77%	87.05%	9.04%	-52.23%	43.60%	-1.71%
ORCL Oracle Corporation	-24.32%	18.13%	59.99%	30.94%	-4.65%	36.89%	24.25%	19.34%	-2.97%	24.94%

Fundamentals

Market Cap SRTS : $64.98M ORCL : $428.68B
EPS SRTS : -$0.47 ORCL : $5.58
PS Ratio SRTS : 2.36 ORCL : 6.67
PB Ratio SRTS : 1.35 ORCL : 10.98
Total Revenue (TTM) SRTS : $27.48M ORCL : $64.08B
Gross Profit (TTM) SRTS : $11.87M ORCL : $58.10B
EBITDA (TTM) SRTS : -$6.71M ORCL : $17.85B

Returns By Period

SRTS

• 1D: 2.84%
• 1M: -3.16%
• YTD: -0.00%
• 6M: 26.75%
• 1Y: -15.86%
• 3Y*: -8.59%
• 5Y*: 0.67%
• 10Y*: —

ORCL

• 1D: 5.99%
• 1M: 1.18%
• YTD: -24.32%
• 6M: -47.46%
• 1Y: 6.29%
• 3Y*: 17.96%
• 5Y*: 17.01%
• 10Y*: 15.30%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SRTS vs. ORCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRTS

SRTS Risk / Return Rank: 32
SRTS Sharpe Ratio Rank: 31
SRTS Sortino Ratio Rank: 35
SRTS Omega Ratio Rank: 35
SRTS Calmar Ratio Rank: 30
SRTS Martin Ratio Rank: 31

ORCL

ORCL Risk / Return Rank: 46
ORCL Sharpe Ratio Rank: 46
ORCL Sortino Ratio Rank: 48
ORCL Omega Ratio Rank: 45
ORCL Calmar Ratio Rank: 45
ORCL Martin Ratio Rank: 45

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SRTS vs. ORCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and Oracle Corporation (ORCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SRTS	ORCL	Difference
Sharpe ratio Return per unit of total volatility	-0.22	0.10	-0.32
Sortino ratio Return per unit of downside risk	0.20	0.68	-0.49
Omega ratio Gain probability vs. loss probability	1.03	1.08	-0.05
Calmar ratio Return relative to maximum drawdown	-0.37	0.09	-0.46
Martin ratio Return relative to average drawdown	-0.61	0.19	-0.80
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SRTS vs. ORCL - Sharpe Ratio Comparison

The current SRTS Sharpe Ratio is -0.22, which is lower than the ORCL Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of SRTS and ORCL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SRTS	ORCL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	0.10	-0.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.01	0.43	-0.42
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.45	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	0.47	-0.53

Correlation

The correlation between SRTS and ORCL is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SRTS vs. ORCL - Dividend Comparison

SRTS has not paid dividends to shareholders, while ORCL's dividend yield for the trailing twelve months is around 1.36%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SRTS Sensus Healthcare, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ORCL Oracle Corporation	1.36%	0.97%	0.96%	1.44%	1.57%	1.38%	1.48%	1.72%	1.68%	1.52%	1.56%	1.56%

Drawdowns

SRTS vs. ORCL - Drawdown Comparison

The maximum SRTS drawdown since its inception was -87.51%, roughly equal to the maximum ORCL drawdown of -84.19%. Use the drawdown chart below to compare losses from any high point for SRTS and ORCL.

Drawdown Indicators

	SRTS	ORCL	Difference
Max Drawdown Largest peak-to-trough decline	-87.51%	-84.19%	-3.32%
Max Drawdown (1Y) Largest decline over 1 year	-45.31%	-58.25%	+12.94%
Max Drawdown (5Y) Largest decline over 5 years	-87.51%	-58.25%	-29.26%
Max Drawdown (10Y) Largest decline over 10 years	—	-58.25%	—
Current Drawdown Current decline from peak	-73.41%	-55.00%	-18.41%
Average Drawdown Average peak-to-trough decline	-46.09%	-29.04%	-17.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.19%	29.42%	-2.23%

Volatility

SRTS vs. ORCL - Volatility Comparison

Sensus Healthcare, Inc. (SRTS) and Oracle Corporation (ORCL) have volatilities of 15.01% and 14.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SRTS	ORCL	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.01%	14.44%	+0.57%
Volatility (6M) Calculated over the trailing 6-month period	49.16%	36.57%	+12.59%
Volatility (1Y) Calculated over the trailing 1-year period	71.98%	61.79%	+10.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.57%	40.03%	+41.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.47%	33.81%	+39.66%

Financials